Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Compare the Efficacy and Safety of Raltegravir Versus Efavirenz Combination Therapy in Treatment-naïve HIV-1 Patients

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Taipei Veterans General Hospital, Taiwan
ClinicalTrials.gov Identifier:
NCT01989910
First received: October 22, 2013
Last updated: January 5, 2016
Last verified: November 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)